Anuv Ratan (Menlo Park) joined KKR in 2017 and is a member of the Health Care Strategic Growth team. He currently serves as a Board Director or Observer for Biosynth, Cordis, Dawn Bio, Gamma Biosciences, Headlands Research, Nordic Bioscience, Precipart, Resolian, Sapphiros, and Zeus Health. He was previously based in London from 2021 to 2022. Prior to joining KKR, Mr. Ratan worked at FFL Partners, where he was involved in a number of health care private equity transactions. Mr. Ratan began his career at The Blackstone Group. He holds an A.B., with honors, in Neurobiology from Harvard University.